U.S. markets closed

Integrated BioPharma, Inc. (INBP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.08000.0000 (0.00%)
At close: 3:39PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/8/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
28.74M21.88M13.93M13.30M10.34M
Enterprise Value 3
38.09M30.53M24.67M21.91M21.57M
Trailing P/E
6.384.923.625.623.89
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
0.570.410.280.260.20
Price/Book (mrq)
3.593.082.303.223.24
Enterprise Value/Revenue 3
0.672.141.631.621.58
Enterprise Value/EBITDA 7
7.0921.5614.1223.6916.78

Trading Information

Stock Price History

Beta (5Y Monthly) -0.03
52-Week Change 3191.89%
S&P500 52-Week Change 348.36%
52 Week High 31.2500
52 Week Low 30.2700
50-Day Moving Average 30.9991
200-Day Moving Average 30.7571

Share Statistics

Avg Vol (3 month) 317.77k
Avg Vol (10 day) 321.48k
Shares Outstanding 529.69M
Implied Shares Outstanding 6N/A
Float 9.3M
% Held by Insiders 167.67%
% Held by Institutions 10.00%
Shares Short (Feb 26, 2009) 4N/A
Short Ratio (Feb 26, 2009) 40
Short % of Float (Feb 26, 2009) 4N/A
Short % of Shares Outstanding (Feb 26, 2009) 40.00%
Shares Short (prior month Jan 29, 2009) 411.75k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 9.02%
Operating Margin (ttm)7.65%

Management Effectiveness

Return on Assets (ttm)11.97%
Return on Equity (ttm)87.76%

Income Statement

Revenue (ttm)56.59M
Revenue Per Share (ttm)1.91
Quarterly Revenue Growth (yoy)0.40%
Gross Profit (ttm)6.73M
EBITDA 4.65M
Net Income Avi to Common (ttm)5.1M
Diluted EPS (ttm)0.1590
Quarterly Earnings Growth (yoy)27.60%

Balance Sheet

Total Cash (mrq)43k
Total Cash Per Share (mrq)0
Total Debt (mrq)9.39M
Total Debt/Equity (mrq)111.34
Current Ratio (mrq)1.34
Book Value Per Share (mrq)0.28

Cash Flow Statement

Operating Cash Flow (ttm)1.45M
Levered Free Cash Flow (ttm)566.5k